慢性腎臓病患者の貧血の治療に対するロクサデスタットの反応を予測するのに役立つ
Tatsuya Murata1,2, Tatsuhito Fukuoka2, Takashi Fujii2
1Department of Clinical Laboratory Science, Faculty of Health Sciences, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Laboratory medicine
|September 1, 2025
まとめ
低酸素誘導因子プロリルヒドロキシラーゼ阻害剤 (HIF-PHI) は慢性腎臓病 (CKD) の貧血に対する有望な効果を示しています. 治療の初期にヘプシジンの濃度が低下すると,治療の効果が予測され,臨床試験に役立ちます.
科学分野:
- 腎臓科
- 血液学
- 薬理学について
背景:
- 貧血は慢性腎臓病 (CKD) の一般的な合併症です.
- 低酸素誘導因子プロリルヒドロキシラーゼ阻害剤 (HIF-PHI) は,慢性腎臓病における貧血の新興治療法である.
- 貧血管理におけるHIF- PHI有効性の予測マーカーが必要である.
研究 の 目的:
- 慢性腎臓病患者の貧血に対するHIF- PHI治療中に鉄代謝マーカーを評価する.
- HIF- PHIを投与された患者の貧血改善の予測要因を特定する.
主な方法:
- 比較研究では,透析を受けていないCKD患者48人が参加しました.
- 患者はエリトポエーシス刺激剤 (エポエチンβペゴール) またはHIF- PHI (ロクサデスタット) を投与された.
- ヘプシジンを含む鉄代謝マーカーは,自動分析器を用いて測定された.
主要な成果:
- ヘモグロビンの濃度は,HIF- PHIとエリトポエーシス刺激剤のグループ間で類似した.
- HIF- PHI治療は,血清鉄,フェリチン,トランスファーリン飽和度,およびヘプシディンを1ヶ月後に低減させた.
- 1ヶ月後のヘプシディン濃度の低下は,3ヶ月後のヘモグロビン濃度の上昇と強く相関していた.
結論:
- ヘプシディンのレベルは,CKDに関連する貧血におけるHIF- PHI反応の早期予測マーカーとして機能する.
- 鉄代謝の重要な指標であるヘプシディンの測定は,標準的な実験室機器を使用して,通常の臨床環境で実行可能である.
関連する概念動画
01:11Renal Failure: Dose Adjustments
152
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
152
01:17Factors Affecting Renal Clearance: Renal Impairment
154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
01:15Renal Drug Excretion: Overview
263
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
263
01:28Renal Drug Excretion: Tubular Secretion
339
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
339
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
267
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
267
01:16Hepatic Drug Excretion: Influencing Factors
214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214